Compare $JSPR vs $NEUP | Chartloom

Compare

$JSPR vs $NEUP

Jasper Therapeutics Inc · Neuphoria Therapeutics Inc

JSPR

Jasper Therapeutics Inc

NEUP

Neuphoria Therapeutics Inc

Compare $JSPR vs $NEUP

Comparing Jasper Therapeutics Inc and Neuphoria Therapeutics Inc

JSPRJasper Therapeutics Inc

NEUPNeuphoria Therapeutics Inc

JSPRJasper Therapeutics Inc

Market cap

$19M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.0%

52W performance

-76.2%

FCF yield

-318.0%

NEUPNeuphoria Therapeutics Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-92.5%

YTD performance

-12.0%

52W performance

-81.7%

FCF yield

-68.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

JSPR

NEUP

Detailed metrics comparison

JSPR

Jasper Therapeutics Inc

NEUP

Neuphoria Therapeutics Inc

Market Cap

JSPR$19M

NEUP$18M

Enterprise Value

JSPR$12M

NEUP$-2M

Price

JSPR$0.57

NEUP$3.36

P/E Ratio

JSPRN/A

NEUPN/A

P/S Ratio

JSPR0.00x

NEUP15.45x

EV/Sales

JSPR0.00x

NEUP-1.44x

EV/EBITDA

JSPR0.00x

NEUP0.00x

P/B Ratio

JSPR13.31x

NEUP0.76x

P/FCF Ratio

JSPRN/A

NEUPN/A

EV/FCF

JSPR-0.19x

NEUP0.14x

PEG Ratio

JSPRN/A

NEUPN/A

Forward P/E (NTM)

JSPRN/A

NEUPN/A

Forward P/S (NTM)

JSPRN/A

NEUPN/A

Revenue (TTM)

JSPR$0

NEUP$1M

Revenue Growth (YoY)

JSPRN/A

NEUP-92.5%

Forward Rev Growth

JSPR-81.1%

NEUP0.0%

Gross Margin (TTM)

JSPR0.0%

NEUP0.0%

Operating Margin (TTM)

JSPR0.0%

NEUP0.0%

EBITDA Margin (TTM)

JSPR0.0%

NEUP-779.0%

Net Margin (TTM)

JSPR0.0%

NEUP-1145.6%

FCF Margin (TTM)

JSPRN/A

NEUP-1052.0%

Net Income (TTM)

JSPR$-32M

NEUP$-13M

FCF (TTM)

JSPR$-60M

NEUP$-12M

EPS (TTM)

JSPR-$1.11

NEUP-$2.49

ROE (TTM)

JSPR-61887.0%

NEUP-5591.0%

ROA (TTM)

JSPR-10067.0%

NEUP-4222.0%

ROIC (TTM)

JSPR-61887.0%

NEUP-5583.0%

Cash

JSPR$7M

NEUP$20M

Debt

JSPR$0

NEUP$34K

Net Cash/Debt

JSPR$7M

NEUP$20M

Current Ratio (TTM)

JSPR1.48x

NEUP27.85x

Quick Ratio (TTM)

JSPR1.02x

NEUP27.33x

Debt/Equity (TTM)

JSPR0.00x

NEUP0.00x

Debt/Assets (TTM)

JSPR0.0%

NEUP0.0%

Interest Coverage (TTM)

JSPRN/A

NEUPN/A

Net Debt/EBITDA (TTM)

JSPR0.00x

NEUP0.00x

Beta

JSPR3.37

NEUP0.76

52W Performance

JSPR-76.2%

NEUP-81.7%

YTD Performance

JSPR-69.0%

NEUP-12.0%

% from 52W High

JSPR-78.8%

NEUP-82.5%

% from 52W Low

JSPR81.0%

NEUP5.3%

Asset Turnover (TTM)

JSPR0.00x

NEUP0.04x

FCF Yield (TTM)

JSPR-318.0%

NEUP-68.1%

Earnings Yield (TTM)

JSPR-167.5%

NEUP-74.1%

Dividend Yield (TTM)

JSPRN/A

NEUPN/A

Rule of 40

JSPR0.0

NEUP-1,144.5

EV/GP/RG

JSPRN/A

NEUPN/A

Ticker research

View JSPR research View NEUP research

Metric	JSPR Jasper Therapeutics Inc	NEUP Neuphoria Therapeutics Inc
Market & Valuation
Market Cap	$19M	$18M
Enterprise Value	$12M	$-2M
Price	$0.57	$3.36
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	15.45x
EV/Sales	0.00x	-1.44x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.31x	0.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.19x	0.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-92.5%
Forward Rev Growth	-81.1%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-779.0%
Net Margin (TTM)	0.0%	-1145.6%
FCF Margin (TTM)	N/A	-1052.0%
Net Income (TTM)	$-32M	$-13M
FCF (TTM)	$-60M	$-12M
EPS (TTM)	-$1.11	-$2.49
ROE (TTM)	-61887.0%	-5591.0%
ROA (TTM)	-10067.0%	-4222.0%
ROIC (TTM)	-61887.0%	-5583.0%
Financial Health
Cash	$7M	$20M
Debt	$0	$34K
Net Cash/Debt	$7M	$20M
Current Ratio (TTM)	1.48x	27.85x
Quick Ratio (TTM)	1.02x	27.33x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.37	0.76
52W Performance	-76.2%	-81.7%
YTD Performance	-69.0%	-12.0%
% from 52W High	-78.8%	-82.5%
% from 52W Low	81.0%	5.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-318.0%	-68.1%
Earnings Yield (TTM)	-167.5%	-74.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,144.5
EV/GP/RG	N/A	N/A
Ticker research	View JSPR research	View NEUP research

Valuation

P/S Ratio

JSPR

0.00x

NEUP

15.45x

EV/FCF

JSPR

-0.19x

NEUP

0.14x

Growth & revenue

Revenue Growth TTM

NEUP

-92.5%

Forward Revenue Growth

NEUP

0.0%

JSPR

-81.1%

Profitability & performance

Gross Margin

JSPR

0.0%

NEUP

0.0%

ROE

NEUP

-5591.0%

JSPR

-61887.0%

FCF Yield %

NEUP

-68.1%

JSPR

-318.0%

52-Week Performance

JSPR

-76.2%

NEUP

-81.7%

Detailed metrics comparison

JSPR

Jasper Therapeutics Inc

NEUP

Neuphoria Therapeutics Inc

Market Cap

JSPR$19M

NEUP$18M

Enterprise Value

JSPR$12M

NEUP$-2M

Price

JSPR$0.57

NEUP$3.36

P/E Ratio

JSPRN/A

NEUPN/A

P/S Ratio

JSPR0.00x

NEUP15.45x

EV/Sales

JSPR0.00x

NEUP-1.44x

EV/EBITDA

JSPR0.00x

NEUP0.00x

P/B Ratio

JSPR13.31x

NEUP0.76x

P/FCF Ratio

JSPRN/A

NEUPN/A

EV/FCF

JSPR-0.19x

NEUP0.14x

PEG Ratio

JSPRN/A

NEUPN/A

Forward P/E (NTM)

JSPRN/A

NEUPN/A

Forward P/S (NTM)

JSPRN/A

NEUPN/A

Revenue (TTM)

JSPR$0

NEUP$1M

Revenue Growth (YoY)

JSPRN/A

NEUP-92.5%

Forward Rev Growth

JSPR-81.1%

NEUP0.0%

Gross Margin (TTM)

JSPR0.0%

NEUP0.0%

Operating Margin (TTM)

JSPR0.0%

NEUP0.0%

EBITDA Margin (TTM)

JSPR0.0%

NEUP-779.0%

Net Margin (TTM)

JSPR0.0%

NEUP-1145.6%

FCF Margin (TTM)

JSPRN/A

NEUP-1052.0%

Net Income (TTM)

JSPR$-32M

NEUP$-13M

FCF (TTM)

JSPR$-60M

NEUP$-12M

EPS (TTM)

JSPR-$1.11

NEUP-$2.49

ROE (TTM)

JSPR-61887.0%

NEUP-5591.0%

ROA (TTM)

JSPR-10067.0%

NEUP-4222.0%

ROIC (TTM)

JSPR-61887.0%

NEUP-5583.0%

Cash

JSPR$7M

NEUP$20M

Debt

JSPR$0

NEUP$34K

Net Cash/Debt

JSPR$7M

NEUP$20M

Current Ratio (TTM)

JSPR1.48x

NEUP27.85x

Quick Ratio (TTM)

JSPR1.02x

NEUP27.33x

Debt/Equity (TTM)

JSPR0.00x

NEUP0.00x

Debt/Assets (TTM)

JSPR0.0%

NEUP0.0%

Interest Coverage (TTM)

JSPRN/A

NEUPN/A

Net Debt/EBITDA (TTM)

JSPR0.00x

NEUP0.00x

Beta

JSPR3.37

NEUP0.76

52W Performance

JSPR-76.2%

NEUP-81.7%

YTD Performance

JSPR-69.0%

NEUP-12.0%

% from 52W High

JSPR-78.8%

NEUP-82.5%

% from 52W Low

JSPR81.0%

NEUP5.3%

Asset Turnover (TTM)

JSPR0.00x

NEUP0.04x

FCF Yield (TTM)

JSPR-318.0%

NEUP-68.1%

Earnings Yield (TTM)

JSPR-167.5%

NEUP-74.1%

Dividend Yield (TTM)

JSPRN/A

NEUPN/A

Rule of 40

JSPR0.0

NEUP-1,144.5

EV/GP/RG

JSPRN/A

NEUPN/A

Ticker research

View JSPR research View NEUP research

Metric	JSPR Jasper Therapeutics Inc	NEUP Neuphoria Therapeutics Inc
Market & Valuation
Market Cap	$19M	$18M
Enterprise Value	$12M	$-2M
Price	$0.57	$3.36
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	15.45x
EV/Sales	0.00x	-1.44x
EV/EBITDA	0.00x	0.00x
P/B Ratio	13.31x	0.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.19x	0.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-92.5%
Forward Rev Growth	-81.1%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-779.0%
Net Margin (TTM)	0.0%	-1145.6%
FCF Margin (TTM)	N/A	-1052.0%
Net Income (TTM)	$-32M	$-13M
FCF (TTM)	$-60M	$-12M
EPS (TTM)	-$1.11	-$2.49
ROE (TTM)	-61887.0%	-5591.0%
ROA (TTM)	-10067.0%	-4222.0%
ROIC (TTM)	-61887.0%	-5583.0%
Financial Health
Cash	$7M	$20M
Debt	$0	$34K
Net Cash/Debt	$7M	$20M
Current Ratio (TTM)	1.48x	27.85x
Quick Ratio (TTM)	1.02x	27.33x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.37	0.76
52W Performance	-76.2%	-81.7%
YTD Performance	-69.0%	-12.0%
% from 52W High	-78.8%	-82.5%
% from 52W Low	81.0%	5.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-318.0%	-68.1%
Earnings Yield (TTM)	-167.5%	-74.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,144.5
EV/GP/RG	N/A	N/A
Ticker research	View JSPR research	View NEUP research